NDC 64661-711

EnLyte

Leucovorin, Folic Acid, Levomefolate Magnesium, Ferrous Cysteine Glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine Calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine Calcium, Phosphatidyl Serine, Pyridoxal 5-phosphate, Flavin Adenine Dinucleotide, Nadh, Cobamamide, Cocarboxylase (thiamine Pyrophosphate), Magnesium Ascorbate, Zinc Ascorbate, Magnesium L-threonate And Betaine

EnLyte is a Oral Capsule, Delayed Release Pellets in the Human Prescription Drug category. It is labeled and distributed by Jaymac Pharmaceuticals Llc. The primary component is Leucovorin; Folic Acid; Levomefolate Magnesium; Ferrous Cysteine Glycinate; 1,2-docosahexanoyl-sn-glycero-3-phosphoserine Calcium; 1,2-icosapentoyl-sn-glycero-3-phosphoserine Calcium; Phosphatidyl Serine; Pyridoxal Phosphate Anhydrous; Flavin Adenine Dinucleotide; Nadh; Cobamamide; Cocarboxylase; Magnesium Ascorbate; Zinc Ascorbate; Magnesium L-threonate; Betaine; Citric Acid Monohydrate; Sodium Citrate.

• Product ID: 64661-711_3c2bbb28-355e-438a-ab53-15693d125ef0
• NDC: 64661-711
• Product Type: Human Prescription Drug
• Proprietary Name: EnLyte
• Generic Name: Leucovorin, Folic Acid, Levomefolate Magnesium, Ferrous Cysteine Glycinate, 1,2-docosahexanoyl-sn-glycero-3-phosphoserine Calcium, 1,2-icosapentoyl-sn-glycero-3-phosphoserine Calcium, Phosphatidyl Serine, Pyridoxal 5-phosphate, Flavin Adenine Dinucleotide, Nadh, Cobamamide, Cocarboxylase (thiamine Pyrophosphate), Magnesium Ascorbate, Zinc Ascorbate, Magnesium L-threonate And Betaine
• Dosage Form: Capsule, Delayed Release Pellets
• Route of Administration: ORAL
• Marketing Start Date: 2011-08-12
• Marketing Category: UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER
• Labeler Name: Jaymac Pharmaceuticals LLC
• Substance Name: LEUCOVORIN; FOLIC ACID; LEVOMEFOLATE MAGNESIUM; FERROUS CYSTEINE GLYCINATE; 1,2-DOCOSAHEXANOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; 1,2-ICOSAPENTOYL-SN-GLYCERO-3-PHOSPHOSERINE CALCIUM; PHOSPHATIDYL SERINE; PYRIDOXAL PHOSPHATE ANHYDROUS; FLAVIN ADENINE DINUCLEOTIDE; NADH; COBAMAMIDE; COCARBOXYLASE; MAGNESIUM ASCORBATE; ZINC ASCORBATE; MAGNESIUM L-THREONATE; BETAINE; CITRIC ACID MONOHYDRATE; SODIUM CITRATE
• Active Ingredient Strength: 3 mg/1; mg/1; mg/1; mg/1; mg/1; ug/1; mg/1; ug/1; ug/1; ug/1; ug/1; ug/1; mg/1; mg/1; mg/1; ug/1; mg/1; mg/1
• Pharm Classes: Folate Analog [EPC],Folic Acid [CS],Vitamin C [EPC],Ascorbic Acid [CS],Vitamin C [EPC],Ascorbic Acid [CS],Methylating Activity [MoA],Methylating Agent [EPC],Acidifying Activity [MoA],Calculi Dissolution Agent [EPC],Anti-coagulant [EPC],Decreased Coagulation Factor Activity [PE],Calcium Chelating Activity [MoA],Osmotic Laxative [EPC],Increased Large Intestinal Motility [PE],Inhibition Large Intestine Fluid/Electrolyte Absorption [PE],Osmotic Activity [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 64661-711-30

30 CAPSULE, DELAYED RELEASE PELLETS in 1 BOTTLE (64661-711-30)

• Marketing Start Date: 2011-08-12
• NDC Exclude Flag: N
• Sample Package?: N

NDC SPL Data Element Entries

NDC 64661-711-30 [64661071130]

EnLyte CAPSULE, DELAYED RELEASE PELLETS

• Marketing Category: unapproved drug other
• Product Type: HUMAN PRESCRIPTION DRUG
• Billing Unit: EA
• Marketing Start Date: 2011-08-12

Drug Details

Active Ingredients

Ingredient	Strength
LEUCOVORIN	2.5 mg/1

OpenFDA Data

• SPL SET ID: e83b2dd3-a9a0-40bc-ade4-6cd4db433b06
• Manufacturer:
  • Jaymac Pharmaceuticals LLC
• UNII:
  • 1VZZ62R081
  • 8B4OP7RK5N
  • F0R1QK73KB
  • 9ABD9DRK7B
  • ZC44YTI8KK
  • 1Q73Q2JULR
  • 3SCV180C9W
  • F06SGE49M6
  • 0N1G678593
  • Q573I9DVLP
  • 1Y26ZZ0OTM
  • 394XK0IH40
  • 2968PHW8QP
  • Q57971654Y
  • 4J24DQ0916
  • 935E97BOY8
  • 6WJM73T46K
  • 9TI35313XW
• PHarm Class EPC:
  • Folate Analog [EPC]
• UPC Code:
  • 0364661711300
• NUI Code:
  • N0000178369
  • N0000175452
  • N0000007151

Pharmacological Class

• Folate Analog [EPC]
• Folic Acid [Chemical/Ingredient]
• Analogs/Derivatives [Chemical/Ingredient]
• Vitamin C [EPC]
• Ascorbic Acid [CS]
• Vitamin C [EPC]
• Ascorbic Acid [CS]
• Methylating Activity [MoA]
• Methylating Agent [EPC]
• Acidifying Activity [MoA]
• Calculi Dissolution Agent [EPC]
• Anti-coagulant [EPC]
• Decreased Coagulation Factor Activity [PE]
• Calcium Chelating Activity [MoA]
• Osmotic Laxative [EPC]
• Increased Large Intestinal Motility [PE]
• Inhibition Large Intestine Fluid/Electrolyte Absorption [PE]
• Osmotic Activity [MoA]

Medicade Reported Pricing

64661071130 ENLYTE SOFTGEL

Pricing Unit: EA | Drug Type: